Search our Database of Scientific Publications and Authors

I’m looking for a

    5025 results match your criteria Actas dermo-sifiliograficas[Journal]

    1 OF 101

    Paradoxical Reactions to Biologic Therapy in Psoriasis: A Review of the Literature.
    Actas Dermosifiliogr 2018 Jun 11. Epub 2018 Jun 11.
    Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.
    Biologic drugs, which are molecules designed to act on specific immune system targets, have been shown to be very effective in treating various dermatological, rheumatological, and systemic diseases. As a group, they have an acceptable safety profile, but their use has been associated with the onset of both systemic and organ-specific inflammatory conditions. True paradoxical reactions are immune-mediated disorders that would usually respond to the biologic agent that causes them. Read More

    Management of Moderate to Severe Psoriasis in Routine Clinical Practice in Spanish Hospitals.
    Actas Dermosifiliogr 2018 Jun 8. Epub 2018 Jun 8.
    Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, España.
    Background: There is currently little information available on the management of patients with psoriasis in the daily clinical practice of dermatologists in Spain.

    Objective: The aim of this study was to survey a group of Spanish dermatologists with particular expertise in the management of psoriasis to determine their opinions on the protocols used in routine clinical practice.

    Material And Methods: A cross-sectional study based on an online survey about the management of psoriasis sent to 75 dermatologists. Read More

    Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016.
    Actas Dermosifiliogr 2018 Jun 7. Epub 2018 Jun 7.
    Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España; Hospital General de Granollers, Granollers, Barcelona, España.
    Introduction And Objectives: Biologic drugs are usually prescribed as second-line treatment for psoriasis, that is, after the patient has first been treated with a conventional psoriasis drug. There are, however, cases where, depending on the characteristics of the patient or the judgement of the physician, biologics may be chosen as first-line therapy. No studies to date have analyzed the demographics or clinical characteristics of patients in this setting or the safety profile of the agents used. Read More

    Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient.
    Actas Dermosifiliogr 2018 Jun 2. Epub 2018 Jun 2.
    Servicio de Dermatología, IIS-FIB, Hospital Universitario de La Princesa. Madrid, España.
    Patients with chronic inflammatory diseases being treated with immunosuppressive drugs, and with tumor necrosis factor inhibitors in particular, have an increased risk of infection by Mycobacterium tuberculosis. Screening for latent tuberculosis infection and preventive therapy to reduce the risk of progression to active tuberculosis are mandatory in this group of patients. This updated multidisciplinary consensus document presents the latest expert opinions on the treatment and prevention of tuberculosis in candidates for biologic therapy and establishes recommendations based on current knowledge relating to the use of biologic agents. Read More

    Practice Models in Teledermatology in Spain: Longitudinal Study, 2009-2014.
    Actas Dermosifiliogr 2018 May 25. Epub 2018 May 25.
    Servicio de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, España.
    Introduction: Teledermatology is the most advanced clinical specialty in telemedicine. The development of teledermatology in specific countries has not been studied in depth.

    Methods: Our objective was to analyze teledermatology models in clinical practice in Spain. Read More

    The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review.
    Actas Dermosifiliogr 2018 May 24. Epub 2018 May 24.
    Servicio de Dermatología, Hospital del Mar, Parc de Salut Mar, Barcelona, España. Electronic address:
    Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in humans and its incidence is rising. Although surgery is the treatment of choice for cSCC, postoperative adjuvant radiotherapy has an important role in local and locorregional disease control. In this review, we analyze the value of postoperative radiotherapy in the management of high-risk cSCC (in particular, cases with perineural invasion), cSCC with positive surgical margins, and locally advanced cSCC (with parotid gland and/or lymph node metastasis). Read More

    Papulopustular Rosacea: Response to Treatment with Oral Azithromycin.
    Actas Dermosifiliogr 2018 Apr 23. Epub 2018 Apr 23.
    Servicio de Dermatología, Hospital Virgen de la Arrixaca, El Palmar, Murcia, España.
    Introduction: Oral tetracyclines and topical antibiotics have been used to treat papulopustular rosacea (PPR) for years, but it is not uncommon to find patients who do not respond to this standard treatment. In such refractory cases, oral azithromycin has proven to be an effective option.

    Material And Method: We conducted a prospective pilot study of 16 patients with PPR who were treated with oral azithromycin after a lack of response to oral doxycycline and metronidazole gel. Read More

    Adult T-Cell Leukemia/Lymphoma. Review of the Literature.
    Actas Dermosifiliogr 2018 Jun 21;109(5):399-407. Epub 2018 Apr 21.
    Servicio de Dermatología, Hospital Nacional Daniel Alcides Carrión, Callao, Perú.
    Adult T-cell Leukemia/Lymphoma (ATLL) is an aggressive neoplasm of T lymphocytes associated with Human T-lymphotropic virus type1 (HTLV-1) infection. HTLV-1 is a public health problem because it is endemic in native groups in Latin America, and its infection leads to several chronic diseases as ATLL. We aimed to review current literature of ATLL in order to consider it as a differential diagnosis in front of patients with compatible symptoms. Read More

    The First Year of the AEVD Primary Cutaneous Lymphoma Registry.
    Actas Dermosifiliogr 2018 Apr 18. Epub 2018 Apr 18.
    Servicio de Dermatología, Hospital Universitario 12 de Octubre, Institute i+12, Medical School. Universidad Complutense, ONCOCIBER, Madrid, España.
    Background And Objective: Primary cutaneous lymphomas are uncommon. This article describes the Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV) and reports on the results from the first year.

    Patients And Methods: Disease registry for patients with primary cutaneous lymphoma. Read More

    Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
    Actas Dermosifiliogr 2018 Apr 12. Epub 2018 Apr 12.
    Servicio de Dermatología, Hospital Ramón y Cajal, Madrid, España.
    Background: Topical minoxidil and oral finasteride are the only drugs approved for the treatment of androgenetic alopecia (AGA) in Spain. However, the management of this condition is highly variable because numerous treatments are used off-label. The main aim of this study was to describe the prescribing habits of dermatologists in Spain for male AGA (MAGA) and female AGA (FAGA). Read More

    Photoallergic Contact Dermatitis to Sunscreens Containing Oxybenzone in La Plata, Argentina.
    Actas Dermosifiliogr 2018 Apr 11. Epub 2018 Apr 11.
    Chemotechnique Diagnostics, Vellinge, Suecia.
    Background: Photoallergic contact dermatitis (PACD) to oxybenzone was reported for the first time in 1980. Oxybenzone is the most common photoallergen in the United States and Canada and the fourth most common .in Europe. Read More

    Lymph Node Dissection in Patients With Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm.
    Actas Dermosifiliogr 2018 Jun 9;109(5):390-398. Epub 2018 Apr 9.
    Servicio de Dermatología, Hospital Universitario La Fe, Valencia, España.
    Recent publication of the results of clinical trials in which lymph node dissection was not associated with any survival benefit in patients with sentinel node metastasis makes it necessary to reconsider the treatment of patients with melanoma. This article provides an update on the available evidence on the diverse factors (routes of metastatic spread, predictors, adjuvant therapy, etc.) that must be considered when treating patients with sentinel node-positive melanoma. Read More

    1 OF 101